← Back to Clinical Trials
Recruiting NCT06342206

NCT06342206 The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06342206
Status Recruiting
Phase
Sponsor China Medical University Hospital
Condition Stroke, Ischemic
Study Type OBSERVATIONAL
Enrollment 24 participants
Start Date 2022-09-08
Primary Completion 2024-09-07

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 24 participants in total. It began in 2022-09-08 with a primary completion date of 2024-09-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cerebral infarction is the second cause of death and the third cause of disability. More than 13.7 million patients worldwide are diagnosed with stroke every year, and the number of deaths is 5.5 million, of which ischemic stroke is the major type, accounting for 87%. Sequelae of stroke are problems that require long-term medical care. If we can intervene and assist with Traditional Chinese Medicine (TCM) at early stage, it will be a great boon for patients. In clinical practice, TCM collects data as the basis for diagnosis through the four diagnostic methods-look, listen, question, and feel the pulse. Among these, tongue diagnosis and pulse diagnosis belong to the categories of look and feel the pulse. At present, the objective examination instruments of TCM developed are mainly tongue diagnostic instruments and pulse diagnostic instruments. Therefore, we hope to utilize tongue and pulse diagnoses as the main reference to analyze the changes in ischemic stroke stages. The data of this study are collected from China Medical University Hospital and YuanRung Hospital-for further statistical analysis. Ischemic stroke patients (ICD-10: I63) who were hospitalized within 1 week from the date of diagnosis were eligible to join this research project. Tongue and pulse examinations were collected once per week within 1 month. A total of 4 tongue-pulse examinations were collected in each case, which were categorized into acute stage (24 hours to 1 week), subacute stage (1 to 3 weeks) and chronic stage (more than 3 weeks). \[30\] This research is to study the changes of tongue and pulse diagnoses in acute, subacute and chronic stages among ischemic patients who receive TCM diagnosis and treatment. Through utilizing objective evaluation of Chinese and Western medical examination instruments, we hope to establish clear diagnostic standards for TCM syndrome types, so as to evaluate the efficacy of clinical diagnosis and treatment. The goal is to improve the quality of TCM care and to provide Chinese and Western integrated treatment for stroke patients in the future. This research can also serve as a reference for related TCM research and development.

Eligibility Criteria

Inclusion Criteria: 1. Patients older than 40 years of age, who acted in concert with the complete examination and answered the questionnaire. 2. Participants were diagnosed as ischemic stroke (ICD-10:I63) by neurologist, and were approved by head CT or MRI examination. 3. Those with a stable vital sign after being examined by an internal medicine specialist 4. Those who experience a cerebral vascular accident within 10 days of the consultation 5. Signing the agreement document to join the research program Exclusion Criteria: 1. Those with an unstable vital sign 2. Patients who were unable to protrude their tongue or the protruding length was insufficient 3. Those at risk of jaw dislocation 4. Those with an arteriovenous shunt or fistula 5. Those who experience seizures 6. Those with poor cognition and communication

Contact & Investigator

Central Contact

Lun-Chien Lo, profession

✉ cmulclo@gmail.com

📞 886-04-22053366

Frequently Asked Questions

Who can join the NCT06342206 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Stroke, Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06342206 currently recruiting?

Yes, NCT06342206 is actively recruiting participants. Contact the research team at cmulclo@gmail.com for enrollment information.

Where is the NCT06342206 trial being conducted?

This trial is being conducted at Changhua, Taiwan.

Who is sponsoring the NCT06342206 clinical trial?

NCT06342206 is sponsored by China Medical University Hospital. The trial plans to enroll 24 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology